Diskussionsleitung: C. Birner (Amberg), R. Braun-Dullaeus (Magdeburg)
| (P910) | The association of CT-assessed fat-free muscle fraction with frailty and malnutrition and the predictive value of their combination in patients undergoing TAVR | |
| B. Al-Kassou, A. M. Sprinkart, M.-C. Schuster, M. Mosler, S. Nowak, J. Shamekhi, A. Aksoy, P. Düsing, M. Weber, F. Jansen, J.-M. Sinning, E. Grube, U. Attenberger, G. Nickenig, J. Luetkens, S. Zimmer (Bonn, Köln) | ||
| (P911) | Computational hemodynamic modeling of aortic valve replacement under resting and stress conditions – a possible methodological approach to predict patient prosthesis mismatch | |
| M. Schafstedde, F. Hellmeier, J. Brüning, J. Nordmeyer, F. Berger, T. Kuehne, L. Goubergrits, S. Nordmeyer (Berlin) | ||
| (P912) | Cardiometabolic Fitness before and after Transcatheter Aortic Valve Implantation (TAVI) – Results from the CORAFIT-Study | |
| M. Boschmann, M. Härdrich, G. Rahn, A. Haase-Fielitz, C. Butter, J. Fielitz (Berlin, Bernau bei Berlin, Greifswald) | ||
| (P913) | Reduction in systolic pulmonary artery pressure after TAVI is associated with lower cardiovascular mortality in patients with severe aortic stenosis | |
| K. Hu, D. Liu, E. Hügel, V. Sokalski, K. Lau, M. Kreipl, B. D. Lengenfelder, G. Ertl, S. Frantz, P. Nordbeck (Würzburg) | ||
| (P914) | Relative longitudinal strain apical sparing pattern and low albumin as detrimental factors of cardiovascular outcome after transcatheter aortic valve replacement | |
| D. Liu, K. Hu, V. Schimpf, V. Sokalski, F. Hermann, K. Lau, B. D. Lengenfelder, G. Ertl, S. Frantz, P. Nordbeck (Würzburg) | ||
| (P915) | A comparison of CHA2DS2VASC and HAS-BLED score with a viscoelastic assay of blood clotting after TAVR | |
| G. Ciccarone, D. Hesselbarth, M. D'Orazio, D. Gjermeni, C. Jülch, T. Pottgießer, C. von zur Mühlen, D. Dürschmied, D. Westermann, C. Olivier (Freiburg im Breisgau, Mannheim) | ||
| (P916) | Incidence and Predictors of Bleeding after Successful Transcatheter Aortic Valve Implantation: An In-Depth Analysis of the ENVISAGE-TAVI AF Trial | |
| G. Dangas, M. Unverdorben, C. Hengstenberg, H. Möllmann, R. Mehran, R. Moreno, L. Nombela-Franco, T. Kimura, D. López-Otero, P. Nordbeck, Y. Watanabe, H.-S. Kim, C. Chen, S. Saito, S. Noble, N. Van Mieghem (New York, Basking Ridge, US; Wien, AT; Dortmund, Würzburg; Madrid, A Coruña, ES; Tokyo, Kamakura, JP; Seoul, KR; Geneva, CH; Rotterdam, NL) | ||
| (P917) | Vergleich einer Monotherapie mit Apixaban versus Rivaroxaban nach Transkatheter-Aortenklappen-Implantation bei bestehender Indikation zur oralen Antikoagulation | |
| C. Kiriakou, N. Meyer, F. Leuschner, M. Konstandin, N. Frey, N. A. Geis (Heidelberg) |